Evaluation of the Beta 2 Adrenoceptor Agonist/Antagonist Activity of Formoterol and Salmeterol.

Thorax - United Kingdom
doi 10.1136/thx.51.1.54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Arginine-16 Β2-Adrenoceptor Polymorphism Predisposes to Bronchoprotective Subsensitivity in Patients Treated With Formoterol and Salmeterol

British Journal of Clinical Pharmacology
Pharmacology
2003English

A Comparative Study of a New Selective Beta 2-Adrenoceptor Agonist, Procaterol and Salbutamol in Asthma.

British Journal of Clinical Pharmacology
Pharmacology
1985English

Pindolol Acts as Beta-Adrenoceptor Agonist in Orthostatic Hypotension.

BMJ
1981English

Long Receptor Residence Time of C26 Contributes to Super Agonist Activity at the Human 2 Adrenoceptor

Molecular Pharmacology
Molecular MedicinePharmacology
2016English

Pindolol Acts as Beta-Adrenoceptor Agonist in Orthostatic Hypotension: Therapeutic Implications.

BMJ
1981English

Stimulation of Insulin Release and cAMP Levels in Isolated Rat Islets by the Imidazoline .ALPHA.2-adrenoceptor Antagonist Midaglizole: Comparison With the Action of the .ALPHA.2-adrenoceptor Antagonist Yohimbine.

Folia Pharmacologica Japonica
Pharmacology
1995English

Erratum to : Pharmacokinetics, Pharmacodynamics, and Safety of Bevantolol, a New Β1-Selective Β-Adrenoceptor Antagonist, in Japanese Healthy Volunteers

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1992English

Metabolic and Cardiovascular Side Effects of the Beta 2-Adrenoceptor Agonists Salbutamol and Rimiterol.

British Journal of Clinical Pharmacology
Pharmacology
1980English

Polymorphism of Beta2-Adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results

ISRN Pulmonology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy